Recruiting OBSERVATIONAL NCT07441499
Using Liquid Biopsy Testing to Identify, Monitor, Predict Recurrence in Urothelial Carcinoma
Sponsor: Tianjin Medical University Second Hospital
Interventions
Multi-Component Liquid Biopsy for Urothelial Carcinoma
Updated 1 time since 2026 Last updated: Feb 27, 2026 Started: Mar 31, 2026 Primary completion: Jan 1, 2027 Completion: Jan 1, 2029
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07441499, this observational or N/A phase trial focuses on Bladder (Urothelial, Transitional Cell) Cancer and Liquid Biopsy and remains actively recruiting participants. Sponsored by Tianjin Medical University Second Hospital, it has been updated 1 time since 2026, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
1 version recorded Recruiting
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Tianjin Medical University Second Hospital
Data source: Tianjin Medical University Second Hospital
For direct contact, visit the study record on ClinicalTrials.gov .